PTC Therapeutics, Inc. (PTCT)
64.35
-2.02
(-3.04%)
USD |
NASDAQ |
Mar 03, 16:00
64.15
-0.20
(-0.31%)
After-Hours: 20:00
PTC Therapeutics Total Liabilities (Quarterly) : 3.117B for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| BioMarin Pharmaceutical, Inc. | 1.507B |
| Sarepta Therapeutics, Inc. | 2.209B |
| Ardelyx, Inc. | 335.86M |
| Spyre Therapeutics, Inc. | 62.54M |
| Ovid Therapeutics, Inc. | 19.15M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.911B |
| Shareholders Equity (Quarterly) | -205.31M |
| Debt to Equity Ratio | -1.942 |
| Current Ratio | 2.348 |
| Net Debt Paydown Yield | 0.00% |